Patients
Rewriting the MASLD playbook
Effective care now requires identifying metabolic risks early and addressing the broader factors driving liver damage.
Digital
Sponsored
Solution Spotlight: InsightBrain – AI-powered precision inte...
InsightBrain gives commercial leaders the signals and direction to deliver stronger launches, defend share, and stay ahead of the competition.
Patients
Every drug is a story, with Thomas Goetz
Thomas Goetz, creator and host of the Drug Story podcast on recognising pharmaceutical medicine as the socially and morally complex market that it is.
R&D
From genetic insight to Phase 3: What rare neurology require...
Rare neurology is not defined by a lack of scientific opportunity or capital.
Digital
Fail fast is not a cultural problem. It is a capital allocat...
Even modest improvements in early predictive resolution can materially shift portfolio economics.
Sales & Marketing
Digital
Market Access
Editor's Picks
Editor's Picks
